• LAST PRICE
    2.4300
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.4000/ 10
  • Ask / Lots
    2.6000/ 1
  • Open / Previous Close
    --- / 2.4300
  • Day Range
    ---
  • 52 Week Range
    Low 1.4300
    High 8.1700
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 2.265
TimeVolumeSYRS
09:32 ET65562.28
09:33 ET2552.2601
09:35 ET12202.2637
09:39 ET14932.2207
09:42 ET4002.2544
09:44 ET5002.255
09:46 ET7002.2585
09:48 ET13212.2474
09:50 ET14002.26
09:51 ET40172.25
09:53 ET10002.2799
09:55 ET16942.279
10:00 ET1002.2774
10:02 ET1002.3
10:04 ET32132.3
10:09 ET4662.325
10:15 ET1002.34
10:20 ET2002.325
10:22 ET5272.34
10:24 ET2272.31
10:26 ET64092.35
10:27 ET78102.389
10:29 ET2002.385
10:31 ET187652.39
10:33 ET130342.4
10:36 ET95502.45
10:38 ET34382.46
10:40 ET54932.48
10:42 ET25912.5009
10:44 ET90622.5299
10:45 ET36022.4609
10:47 ET4862.43
10:49 ET88802.4108
10:51 ET5002.425
10:54 ET2042.4397
10:56 ET91422.47
10:58 ET85992.47
11:00 ET30002.4799
11:02 ET4502.4743
11:03 ET1172.475
11:05 ET2002.4799
11:07 ET15792.46
11:09 ET2002.4636
11:12 ET123902.49
11:14 ET30002.49
11:16 ET26402.5099
11:18 ET11002.52
11:20 ET7972.51
11:21 ET46592.4843
11:25 ET18712.5226
11:27 ET37002.51
11:30 ET6002.5
11:32 ET7062.5
11:38 ET61002.465
11:39 ET11882.45
11:41 ET2002.45
11:45 ET44002.4546
11:50 ET1162.4574
11:52 ET20042.465
11:56 ET4322.45
11:57 ET9162.45
11:59 ET2492.46
12:01 ET6762.46
12:03 ET8912.47
12:06 ET3002.4684
12:08 ET21342.468
12:12 ET73712.45
12:19 ET5352.4301
12:24 ET3002.45
12:26 ET2002.44
12:28 ET7242.45
12:35 ET5002.46
12:37 ET27522.44
12:39 ET6182.44
12:42 ET18002.4413
12:44 ET1902.4402
12:48 ET3002.44
12:50 ET9002.45
12:51 ET11002.45
12:55 ET18502.48
12:57 ET10002.4756
01:00 ET21002.5
01:02 ET5122.49
01:06 ET8002.4809
01:08 ET32802.5
01:11 ET7502.48
01:18 ET6002.48
01:20 ET2002.48
01:26 ET10002.465
01:27 ET10102.47
01:31 ET8872.48
01:38 ET4002.48
01:44 ET42292.4906
01:47 ET8802.49
01:49 ET1002.4809
01:51 ET81632.5
01:54 ET37652.4902
01:58 ET18502.46
02:02 ET75502.45
02:07 ET4002.4521
02:09 ET1002.47
02:12 ET10002.46
02:14 ET24592.45
02:16 ET2002.46
02:18 ET113002.45
02:20 ET3272.4409
02:21 ET31002.43
02:23 ET26352.45
02:32 ET121422.44
02:34 ET2002.45
02:38 ET2002.45
02:39 ET2002.46
02:43 ET7002.46
02:45 ET7002.45
02:48 ET31382.45
02:50 ET2002.45
02:52 ET2002.45
02:54 ET1002.45
02:56 ET1002.45
02:57 ET15682.47
02:59 ET3802.4714
03:01 ET4672.52
03:03 ET30002.495
03:06 ET9372.4947
03:08 ET3002.52
03:10 ET11802.47
03:12 ET5502.495
03:14 ET39802.5
03:15 ET4002.48
03:17 ET9002.5
03:19 ET10002.485
03:21 ET22002.485
03:24 ET8222.49
03:28 ET14672.485
03:30 ET44102.5
03:32 ET20002.4999
03:33 ET2002.48
03:35 ET16702.4793
03:37 ET22152.45
03:39 ET15002.4408
03:42 ET27002.435
03:44 ET33002.44
03:46 ET1002.45
03:48 ET27402.465
03:50 ET5682.46
03:51 ET50802.44
03:53 ET40772.455
03:55 ET21192.46
03:57 ET77452.445
04:00 ET136232.43
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesSYRS
Syros Pharmaceuticals Inc
65.2M
-0.8x
---
United StatesATRA
Atara Biotherapeutics Inc
65.9M
-0.3x
---
United StatesAFMD
Affimed NV
49.8M
-0.6x
---
United StatesCLSD
Clearside Biomedical Inc
77.0M
-2.1x
---
United StatesCLGN
Collplant Biotechnologies Ltd
42.5M
-2.4x
---
United StatesCRIS
Curis Inc
36.0M
-0.5x
---
As of 2024-11-05

Company Information

Syros Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing new standards of care for the frontline treatment of patients with hematologic malignancies. The Company is advancing Tamibarotene, a selective retinoic acid receptor alpha (RARα), agonist for which the Company is conducting SELECT-MDS-1, a Phase III clinical trial evaluating tamibarotene in combination with azacitidine in a genomically defined subset of patients with higher-risk myelodysplastic syndrome (HR-MDS), and for which it is conducting SELECT-AML-1, a randomized Phase II clinical trial evaluating tamibarotene in combination with venetoclax and azacitidine in a genomically defined subset of newly diagnosed patients with acute myeloid leukemia (AML). Its other assets include SY-2101 and SY-5609. The Company is seeking out-licensing opportunities for the further development of SY-5609, its highly selective and potent inhibitor of cyclin dependent kinase 7 (CDK7).

Contact Information

Headquarters
35 Cambridge Park DriveCAMBRIDGE, MA, United States 02140
Phone
617-744-1340
Fax
617-744-1377

Executives

Independent Chairman of the Board
Peter Wirth
President, Chief Executive Officer, Director
Conley Chee
Chief Financial Officer
Jason Haas
Chief Legal and Compliance Officer
Gerald Quirk
Chief Medical Officer
David Roth

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$65.2M
Revenue (TTM)
$386.0K
Shares Outstanding
26.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.60
EPS
$-3.03
Book Value
$0.63
P/E Ratio
-0.8x
Price/Sales (TTM)
168.9
Price/Cash Flow (TTM)
---
Operating Margin
-28,927.20%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.